Ignite Creation Date:
2024-05-05 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00773240
Status:
COMPLETED
Last Update Posted:
2011-08-30
First Post:
2008-10-15
Brief Title:
A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment
Sponsor:
ALK-Abelló AS
Organization:
ALK-Abelló AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2008-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-15
First Submit QC Date:
October 15 2008
Study First Post Date:
2008-10-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-08-27
Last Update Post Date:
2011-08-30
Last Update Post Date Type:
ESTIMATED